← Back to Tools-Radar

FidoCure logo

FidoCure

Categories: Healthcare, Data Analysis, Research  |  Pricing: Freemium  |  Official Website ↗

FidoCure provides AI-enabled personalized therapeutic recommendations for canine cancer treatment based on genomic testing and tumor profiling.

FidoCure, developed by One Health Company, offers an AI-enabled platform for personalized canine cancer treatment. It utilizes genomic testing and tumor profiling to identify cancer-driving mutations in dogs. Based on these insights, the platform recommends targeted therapeutic options tailored to each dog's individual needs, moving beyond standard chemotherapy and radiation. The company has sequenced, treated, and collected data from thousands of dogs, building a proprietary cancer dataset. This data is used to generate real-world evidence, coupling genomic biomarkers with therapeutic outcomes, and informing ongoing scientific research and innovation in therapeutic treatments for canine cancer. FidoCure aims to make effective canine cancer treatment more accessible and also contributes to comparative oncology research, exploring shared mutations between dogs and humans to advance cancer therapeutics for both species.

Key Features

Pros

Cons

Use Cases

Best For

Platforms: Web

Watch demo on YouTube ↗


View full FidoCure profile on Tools-Radar | Browse Healthcare tools | Alternatives to FidoCure

Tools-Radar is a free directory of 10,000+ AI tools — discover, compare, and choose the right AI software for your needs. Visit tools-radar.com